C Jaimes1,2, V Rofeberg1, C Stopp1, C M Ortinau3, A Gholipour1,2, K G Friedman1,2, W Tworetzky1,2, J Estroff1,2, J W Newburger1,2, D Wypij1,2,4, S K Warfield1,2, E Yang1,2, C K Rollins5,2. 1. From the Departments of Radiology (C.J., A.G., J.E., S.K.W., E.Y.), Cardiology (V.R., C.S., K.G.F., W.T., J.W.N., D.W.), Neurology (C.K.R.), Fetal-Neonatal Neuroimaging and Developmental Science Center (C.J.), Boston Children's Hospital, Boston, Massachusetts. 2. Radiology (C.J., A.G., J.E., S.K.W., E.Y.), Pediatrics (K.G.F., W.T., J.W.N., D.W.), Neurology (C.K.R.), Harvard Medical School, Boston, Massachusetts. 3. Pediatrics (C.M.O.), Washington University in St. Louis, St. Louis, Missouri. 4. Biostatistics (D.W.), Harvard T.H. Chan School of Public Health, Boston, Massachusetts. 5. From the Departments of Radiology (C.J., A.G., J.E., S.K.W., E.Y.), Cardiology (V.R., C.S., K.G.F., W.T., J.W.N., D.W.), Neurology (C.K.R.), Fetal-Neonatal Neuroimaging and Developmental Science Center (C.J.), Boston Children's Hospital, Boston, Massachusetts caitlin.rollins@childrens.harvard.edu.
Abstract
BACKGROUND AND PURPOSE: Brain MRI of newborns with congenital heart disease show signs of immaturity relative to healthy controls. Our aim was to determine whether the semiquantitative fetal total maturation score can detect abnormalities in brain maturation in fetuses with congenital heart disease in the second and third trimesters. MATERIALS AND METHODS: We analyzed data from a prospective study of fetuses with and without congenital heart disease who underwent fetal MR imaging at 25-35 weeks' gestation. Two independent neuroradiologists blinded to the clinical data reviewed and scored all images using the fetal total maturation score. Interrater reliability was evaluated by the intraclass correlation coefficient using the individual reader scores, which were also used to calculate an average score for each subject. Comparisons of the average and individual reader scores between affected and control fetuses and relationships with clinical variables were evaluated using multivariable linear regression. RESULTS: Data from 69 subjects (48 cardiac, 21 controls) were included. High concordance was observed between readers with an intraclass correlation coefficient of 0.98 (95% CI, 0.97-0.99). The affected group had significantly lower fetal total maturation scores than the control group (β-estimate, -0.9 [95% CI, -1.5 to -0.4], P = .002), adjusting for gestational age and sex. Averaged fetal total maturation, germinal matrix, myelination, and superior temporal sulcus scores were significantly delayed in fetuses with congenital heart disease versus controls (P < .05 for each). The fetal total maturation score was not significantly associated with any cardiac, anatomic, or physiologic variables. CONCLUSIONS: The fetal total maturation score is sensitive to differences in brain maturation between fetuses with isolated congenital heart disease and healthy controls.
BACKGROUND AND PURPOSE: Brain MRI of newborns with congenital heart disease show signs of immaturity relative to healthy controls. Our aim was to determine whether the semiquantitative fetal total maturation score can detect abnormalities in brain maturation in fetuses with congenital heart disease in the second and third trimesters. MATERIALS AND METHODS: We analyzed data from a prospective study of fetuses with and without congenital heart disease who underwent fetal MR imaging at 25-35 weeks' gestation. Two independent neuroradiologists blinded to the clinical data reviewed and scored all images using the fetal total maturation score. Interrater reliability was evaluated by the intraclass correlation coefficient using the individual reader scores, which were also used to calculate an average score for each subject. Comparisons of the average and individual reader scores between affected and control fetuses and relationships with clinical variables were evaluated using multivariable linear regression. RESULTS: Data from 69 subjects (48 cardiac, 21 controls) were included. High concordance was observed between readers with an intraclass correlation coefficient of 0.98 (95% CI, 0.97-0.99). The affected group had significantly lower fetal total maturation scores than the control group (β-estimate, -0.9 [95% CI, -1.5 to -0.4], P = .002), adjusting for gestational age and sex. Averaged fetal total maturation, germinal matrix, myelination, and superior temporal sulcus scores were significantly delayed in fetuses with congenital heart diseaseversus controls (P < .05 for each). The fetal total maturation score was not significantly associated with any cardiac, anatomic, or physiologic variables. CONCLUSIONS: The fetal total maturation score is sensitive to differences in brain maturation between fetuses with isolated congenital heart disease and healthy controls.
Authors: C Garel; E Chantrel; H Brisse; M Elmaleh; D Luton; J F Oury; G Sebag; M Hassan Journal: AJNR Am J Neuroradiol Date: 2001-01 Impact factor: 3.825
Authors: Catherine Limperopoulos; Wayne Tworetzky; Doff B McElhinney; Jane W Newburger; David W Brown; Richard L Robertson; Nicolas Guizard; Ellen McGrath; Judith Geva; David Annese; Carolyn Dunbar-Masterson; Bethany Trainor; Peter C Laussen; Adré J du Plessis Journal: Circulation Date: 2009-12-21 Impact factor: 29.690
Authors: C Clouchoux; A J du Plessis; M Bouyssi-Kobar; W Tworetzky; D B McElhinney; D W Brown; A Gholipour; D Kudelski; S K Warfield; R J McCarter; R L Robertson; A C Evans; J W Newburger; C Limperopoulos Journal: Cereb Cortex Date: 2012-09-12 Impact factor: 5.357
Authors: Daniel J Licht; David M Shera; Robert R Clancy; Gil Wernovsky; Lisa M Montenegro; Susan C Nicolson; Robert A Zimmerman; Thomas L Spray; J William Gaynor; Arastoo Vossough Journal: J Thorac Cardiovasc Surg Date: 2009-03 Impact factor: 5.209
Authors: Bernhard Kainz; Markus Steinberger; Wolfgang Wein; Maria Kuklisova-Murgasova; Christina Malamateniou; Kevin Keraudren; Thomas Torsney-Weir; Mary Rutherford; Paul Aljabar; Joseph V Hajnal; Daniel Rueckert Journal: IEEE Trans Med Imaging Date: 2015-03-20 Impact factor: 10.048
Authors: Cynthia M Ortinau; Kathryn Mangin-Heimos; Joseph Moen; Dimitrios Alexopoulos; Terrie E Inder; Ali Gholipour; Joshua S Shimony; Pirooz Eghtesady; Bradley L Schlaggar; Christopher D Smyser Journal: Neuroimage Clin Date: 2018-09-27 Impact factor: 4.881
Authors: F Machado-Rivas; O Afacan; S Khan; B Marami; C K Rollins; C Ortinau; C Velasco-Annis; S K Warfield; A Gholipour; C Jaimes Journal: AJNR Am J Neuroradiol Date: 2021-01 Impact factor: 3.825
Authors: Sheila M Everwijn; Jiska F van Bohemen; Nan van Geloven; Fenna A Jansen; Aalbertine K Teunissen; Lieke Rozendaal; Nico Blom; Jan M van Lith; Monique C Haak Journal: Prenat Diagn Date: 2021-09-19 Impact factor: 3.242